Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Biochemical Pharmacology

• Publication date

  2005-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BCP.2005.04.043PMID 16023083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a p65 Peptide That Selectively Inhibits NF-κ B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-κB-mediated Gene Expression and Up-regulation of Apoptosis*

  2004influential reference
• PI 3-kinase, Akt and cell survival.

  2004cited by this paper
• Establishment and Characterization of a New Mantle Cell Lymphoma Cell Line M-1

  2004cited by this paper
• Abnormal expression of apoptosis‐related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma

  2003cited by this paper
• Anticancer potential of curcumin: preclinical and clinical studies.

  2003cited by this paper
• Ursolic Acid Inhibits Nuclear Factor-κB Activation Induced by Carcinogenic Agents through Suppression of IκBα Kinase and p65 Phosphorylation: Correlation with Down-Regulation of Cyclooxygenase 2, Matrix Metalloproteinase 9, and Cyclin D1

  2003cited by this paper
• Inhibition of Constitutive NF-κB Activation in Mantle Cell Lymphoma B Cells Leads to Induction of Cell Cycle Arrest and Apoptosis1

  2003cited by this paper
• Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.

  2003influential reference
• Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis

  2003cited by this paper
• The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.

  2003cited by this paper
• Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.

  2003cited by this paper
• Characterization of 4 mantle cell lymphoma cell lines.

  2003cited by this paper
• Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2.

  2003cited by this paper
• Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.

  2003cited by this paper
• Bcl‐2 family of proteins in indolent B‐cell non‐Hodgkin's lymphoma: Study of 116 cases

  2002cited by this paper
• Nuclear Factor-κB Activation: A Question of Life or Death

  2002cited by this paper
• Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl.

  2002cited by this paper
• Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma.

  2002cited by this paper
• Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation

  2002cited by this paper
• Nuclear factor-kappaB activation: a question of life or death.

  2002cited by this paper
• Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells.

  2002cited by this paper
• Establishment and characterization of a new mantle cell lymphoma cell line, Mino.

  2002cited by this paper
• RANK (receptor activator of nuclear factor‐κB) and RANKL expression in multiple myeloma

  2002cited by this paper
• Missing pieces in the NF-kappaB puzzle.

  2002cited by this paper
• Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment.

  2001cited by this paper
• Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

  2001cited by this paper
• Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis.

  2001cited by this paper
• Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines

  2001cited by this paper
• The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition

  2001cited by this paper
• Analysis of expression of nuclear factor κB (NF‐κB) in multiple myeloma: downregulation of NF‐κB induces apoptosis

  2001cited by this paper
• Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

  2000influential reference
• European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.

  2000cited by this paper
• Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.

  2000cited by this paper
• Autologous hematopoietic stem cell transplantation for mantle cell lymphoma.

  2000cited by this paper
• Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma.

  2000cited by this paper
• Assay for redox-sensitive transcription factor.

  2000cited by this paper
• Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group

  2000cited by this paper
• Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages.

  2000cited by this paper
• Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex

  1999cited by this paper
• Mantle-cell lymphoma.

  1999cited by this paper
• Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.

  1999cited by this paper
• Blood Concentrations of Tumor Necrosis Factor-Alpha in Malignant Lymphomas and Their Decrease as a Predictor of Disease Control in Response to Low-Dose Subcutaneous Immunotherapy with Interleukin-2

  1999influential reference
• Activators and target genes of Rel/NF-kappaB transcription factors.

  1999cited by this paper
• Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas.

  1999cited by this paper
• NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase

  1999cited by this paper
• Overexpression of Manganese Superoxide Dismutase Suppresses Tumor Necrosis Factor-induced Apoptosis and Activation of Nuclear Transcription Factor-κB and Activated Protein-1*

  1998cited by this paper
• Establishment and characterization of a mantle cell lymphoma cell line

  1998cited by this paper
• Mantle cell lymphoma: a retrospective study of 121 cases

  1998cited by this paper
• Caspases: the proteases of the apoptotic pathway

  1998influential reference
• Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1.

  1998cited by this paper
• Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates.

  1998cited by this paper
• NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

  1998influential reference
• IkappaB kinase: beginning, not the end.

  1997influential reference
• IκB kinase: Beginning, not the end

  1997cited by this paper
• Apoptosis: Activate NF-κB or die?

  1997cited by this paper
• NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.

  1997cited by this paper
• Activate NF-kappa B or die?

  1997cited by this paper
• Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.

  1996cited by this paper
• Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors.

  1996cited by this paper
• Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected].

  1995cited by this paper
• Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*)

  1995cited by this paper
• Mantle cell lymphoma.

  1994cited by this paper
• Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors.

  1993cited by this paper
• Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias.

  1993cited by this paper
• Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.

  1991cited by this paper
• Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis

  1989cited by this paper
• The establishment of epstein‐barr virus nuclear antigen‐positive (SP‐50B) and epstein‐barr virus nuclear antigen‐negative (SP‐53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma

  1989cited by this paper
• Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation.

  1984cited by this paper

• Curcumin Supplementation in Critically Ill Patients: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trial.

  2026cites this paper
• Research Progress on the Treatment of Ulcerative Colitis Targeting the NF-κB Signaling Pathway

  2026cites this paper
• Synergistic Mechanisms of Traditional Chinese Medicine and Proteasome Inhibitors in Multiple Myeloma Therapy: A Comprehensive Review

  2025cites this paper
• A review on integrative approaches in oncology: bridging ayurvedic medicine and modern cancer therapeutics

  2025cites this paper
• Ameliorative effect of curcuminoids in liver fibrosis rat model via regulating GIPC1 gene and modulating MMP-8/TIMP-3 balance mediated by miR-483-5p

  2025cites this paper
• Mechanistic insights and clinical perspectives on anticancer natural compounds from dietary polyphenols

  2025cites this paper
• Natural anti-cancer products: insights from herbal medicine

  2025cites this paper
• Lactic acid bacteria target NF-κB signaling to alleviate gastric inflammation.

  2025cites this paper
• Curcumin in treatment of hematological cancers: Promises and challenges

  2024cites this paper
• Mitochondria-targeted BODIPY dyes for small molecule recognition, bio-imaging and photodynamic therapy.

  2024cites this paper
• An overview of the efficacy of inhaled curcumin: a new mode of administration for an old molecule.

  2024cites this paper
• Efficacy and safety of dietary polyphenol administration as assessed by hormonal, glycolipid metabolism, inflammation and oxidative stress parameters in patients with PCOS: a meta-analysis and systematic review

  2024cites this paper
• The Effects of Curcumin Plus Piperine Co-administration on Inflammation and Oxidative Stress: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

  2024cites this paper
• Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance

  2024cites this paper
• Evaluation of the effectiveness of curcumin and piperine co-supplementation on inflammatory factors, cardiac biomarkers, atrial fibrillation, and clinical outcomes after coronary artery bypass graft surgery.

  2024cites this paper
• Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma

  2024cites this paper
• Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity

  2024cites this paper
• Soothing the Itch: The Role of Medicinal Plants in Alleviating Pruritus in Palliative Care

  2024cites this paper
• Biocompatibility and potential anticancer activity of gadolinium oxide (Gd2O3) nanoparticles against nasal squamous cell carcinoma

  2024cites this paper
• Regulation of Acetylation States by Nutrients in the Inhibition of Vascular Inflammation and Atherosclerosis

  2023cites this paper
• Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives.

  2023cites this paper
• Curcumin reduces paclitaxel resistance in ovarian carcinoma cells by upregulating SNIP1 and inhibiting NFκB activity.

  2023cites this paper
• Biological Potential and Bioaccessibility of Encapsulated Curcumin into Cetyltrimethylammonium Bromide Modified Cellulose Nanocrystals

  2023cites this paper
• Bioactive Compounds as Inhibitors of Inflammation, Oxidative Stress and Metabolic Dysfunctions via Regulation of Cellular Redox Balance and Histone Acetylation State

  2023cites this paper
• Curcumin effects on Leydig cell functions and potential therapeutic uses

  2023cites this paper
• Protective effects of curcumin and its analogues via the Nrf2 pathway in metabolic syndrome.

  2023cites this paper
• Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma

  2023cites this paper
• Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: New trends and future perspectives in cancer therapy

  2023cites this paper
• Characterization of Electrospun BDMC-Loaded PLA Nanofibers with Drug Delivery Function and Anti-Inflammatory Activity

  2023cites this paper
• Nanotechnology-based strategies for effective delivery of phytoconstituents for the management of rheumatoid arthritis

  2022cites this paper
• MicroRNA-140-5p inhibits cellular proliferation, migration and invasion by downregulating AKT/STAT3/NF-κB pathway in breast carcinoma cells

  2022cites this paper
• Curcumin as a Natural Modulator of B Lymphocytes: Evidence from In Vitro and In Vivo Studies.

  2022cites this paper
• A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer

  2022cites this paper
• Anti-Inflammatory Effects of Nano- Curcumin on a Glioblastoma Cell Line

  2022cites this paper
• Micellar Curcumin Substantially Increases the Antineoplastic Activity of the Alkylphosphocholine Erufosine against TWIST1 Positive Cutaneous T Cell Lymphoma Cell Lines

  2022cites this paper
• Curcumin: A dietary phytochemical for boosting exercise performance and recovery

  2022cites this paper
• Randomized Control Study of the Effects of Turmeric Mouthwash on Oral Health Status, Treatment-Induced Mucositis, and Associated Oral Dysfunctions Among Patients With Head and Neck Cancer

  2022cites this paper
• Therapeutic Importance of Curcumin with a Special Emphasis on Mdr Cancer Cells and the Factors Influencing Pharmacodynamics

  2022cites this paper
• Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules

  2022cites this paper
• Antiproliferation and Apoptosis Effect of Cisplatin and Nanocurcumin on Ovarian Cancer SKOV3 Cell

  2022cites this paper
• Interaction of curcumin with glioblastoma cells via high and low linear energy transfer radiation therapy inducing radiosensitization effects

  2022cites this paper
• Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy

  2022cites this paper
• Zingiberaceae plants/curcumin consumption and multiple health outcomes: An umbrella review of systematic reviews and meta‐analyses of randomized controlled trials in humans

  2022cites this paper
• Polyphenols target miRNAs as a therapeutic strategy for diabetic complications

  2022cites this paper
• Therapeutic effect and safety of curcumin in women with PCOS: A systematic review and meta-analysis

  2022cites this paper
• CURCUMIN IN SITU GEL FOR LOCAL TREATMENT OF PERIODONTITIS: PREPARATION, IN VITRO EVALUATION AND CLINICAL ASSESSMENT

  2022cites this paper
• Prodrug Polymeric Nanoconjugates Encapsulating Gold Nanoparticles for Enhanced X‐Ray Radiation Therapy in Breast Cancer

  2021cites this paper
• Anti-Dislipidemia Effectiveness Test of Turmeric Ethanol Extract (Curcuma Longa) in Male Wistar Mice Given a High-Fat Diet

  2021cites this paper
• Effect of curcumin on C‐reactive protein as a biomarker of systemic inflammation: An updated meta‐analysis of randomized controlled trials

  2021cites this paper
• Anti-Genotoxicity Evaluation of Ellagic Acid and Curcumin—An In Vitro Study on Zebrafish Blood Cells

  2021cites this paper
• Anti-Dislipidemia Effectiveness Test of Turmeric Ethanol Extract (Curcuma Longa) in Male Wistar Mice Given Propylthiouracil (PTU)

  2021cites this paper
• Curcumin Can Bind and Interact with CRP: An in silico Study.

  2021cites this paper
• Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled trials.

  2021cites this paper
• Functionalized polylysine biomaterials for advanced medical applications: A review

  2021cites this paper
• Treatment of lymphomas via regulating the Signal transduction pathways by natural therapeutic approaches: A review.

  2021cites this paper
• Potential Effects of Nutraceuticals in Retinopathy of Prematurity

  2021cites this paper
• Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases

  2021cites this paper
• Spice up your food for cancer prevention: Cancer chemo-prevention by natural compounds from common dietary spices

  2021cites this paper
• Curcumin Innovative Delivery Forms: Paving the ‘Yellow Brick Road’ of Antitumoral Phytotherapy

  2020cites this paper
• Phytochemicals and cancer chemoprevention

  2020cites this paper
• Curcumin in combination: Review of synergistic effects and mechanisms in the treatment of inflammation

  2020cites this paper
• Recent Advances in Curcumin Treated Non-Small Cell Lung Cancers: An Impetus of Pleiotropic Traits and Nanocarrier Aided Delivery.

  2020cites this paper
• COVID‐19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?

  2020cites this paper
• Comparative Evaluation of in Vitro Antioxidant, Amylase Inhibition and Cytotoxic Activity of Cur-Pip Dual Drug Loaded Nanoparticles

  2020cites this paper
• Mitochondria-Targeted Polyamidoamine Dendrimer-Curcumin Construct for Hepatocellular Cancer Treatment.

  2020cites this paper
• Phytochemicals in Cancer Chemoprevention: A Brief Perspective

  2020cites this paper
• Can Brain Health Be Supported by Vitamin D-Based Supplements? A Critical Review

  2020cites this paper
• Mantle Cell Lymphoma: Definition, Epidemiology, Pathobiology – Lymphomagenesis, Morphology, Variants, Immunophenotype, Prognostic Factors

  2020cites this paper
• Delineating role of NF‐κB and interacting cytokines during prostate cancer‐induced osteoclastogenesis

  2020cites this paper
• A Review on Anti-Tumor Mechanisms of Coumarins

  2020cites this paper
• Follicular Lymphoma and Mantle Cell Lymphoma: Pathobiology, Diagnosis and Treatment

  2020cites this paper
• Nanoceria-curcumin conjugate: Synthesis and selective cytotoxicity against cancer cells under oxidative stress conditions.

  2020cites this paper
• Effects of free and nanoparticulate curcumin on chemically induced liver carcinoma in an animal model

  2020cites this paper
• Curcumin effect on cancer cells' multidrug resistance: An update

  2020cites this paper
• Curcumin in cancer prevention and therapy

  2020cites this paper
• The Effect of Curcumin Supplementation and Aerobic Training on Anthropometric Indices, Serum Lipid Profiles, C-Reactive Protein and Insulin Resistance in Overweight Women: A Randomized, Double-Blind, Placebo-Controlled Trial

  2020cites this paper
• Curcumin Affects Gastric Cancer Cell Migration, Invasion and Cytoskeletal Remodeling Through Gli1-β-Catenin

  2020cites this paper
• Uev1A amino terminus stimulates poly-ubiquitin chain assembly and is required for NF-κB activation.

  2020cites this paper
• Anacardic acid mitigates liver fat accumulation and impaired glucose tolerance in mice fed a high‐fat and high‐sucrose diet

  2020cites this paper
• Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer

  2020cites this paper
• UCP2 promotes proliferation and chemoresistance through regulating the NF-κB/β-catenin axis and mitochondrial ROS in gallbladder cancer.

  2019cites this paper
• Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments

  2019cites this paper
• Anti-cancer activity of Conyza blinii saponin against cervical carcinoma through MAPK/TGF-β/Nrf2 signaling pathways.

  2019cites this paper
• The β-cyclodextrin-modified nanosized ZSM-5 zeolite as a carrier for curcumin

  2019cites this paper
• Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway

  2019cites this paper
• Inhibition Activity of Curcumin-Loaded Sterically Stabilized Micelles and Its Up-Regulator Effect on Enhancement of Cytotoxicity of a New Nano-Pirarubicin Formulation in the Treatment of Breast Cancer

  2019cites this paper
• Evaluation of a curcumin-containing mucoadhesive film for periodontal postsurgical pain control

  2019cites this paper
• A green method for preparation of curcuminoid-rich Curcuma longa extract and evaluation of its anticancer activity

  2019cites this paper
• Is curcumin bioavailability a problem in humans: lessons from clinical trials

  2019cites this paper
• NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease.

  2019cites this paper
• Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects

  2019cites this paper
• Targeting the balance of T helper cell responses by curcumin in inflammatory and autoimmune states.

  2019cites this paper
• Molecular mechanism of plant stress hormone methyl jasmonate for its anti-inflammatory activity

  2019cites this paper
• Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells

  2019cites this paper
• Green silver nanoparticle and Tween-20 modulated pro-oxidant to antioxidant curcumin transformation in aqueous CTAB stabilized peanut oil emulsions

  2019cites this paper
• Host genetic variation in tumor necrosis factor and nuclear factor‐κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study

  2019cites this paper
• Haploidentical bone marrow transplantation improves cerebral hemodynamics in adults with sickle cell disease

  2019cites this paper
• Calcium promotes differentiation in ameloblast-like LS8 cells by downregulation of phosphatidylinositol 3 kinase /protein kinase B pathway.

  2019cites this paper
• Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells

  2018cites this paper
• Title Magnetic Alginate / Chitosan Nanoparticles for Targeted Delivery of Curcumin into Human Breast Cancer Cells

  2018cites this paper